![Robert Peach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Peach
Directeur/Bestuurslid bij
AMPLIA THERAPEUTICS LIMITED
Vermogen: 466 050 $ op 31-05-2026
Profiel
Robert J.
Peach was the founder of Apoptos, Inc. (2007) as Vice President-Biology and Receptos LLC (2009) as Chief Scientific Officer.
Dr. Peach is currently an Independent Non-Executive Director at Amplia Therapeutics Ltd. since 2015.
Former positions include Senior Director-Oncology Discovery at Biogen, Inc. (2005-2007), Director at Avalia Immunotherapies Ltd., Independent Non-Executive Director at AdAlta Ltd. (2016-2024), and Principal at Bristol Myers Squibb Co. (1991-2000).
Education includes a doctorate from the University of Otago and undergraduate and graduate degrees from the University of Canterbury.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-09-2025 | 4.798.212 ( 0,93% ) | 466 050 $ | 31-05-2026 |
Actieve functies van Robert Peach
| Bedrijven | Functie | Begin |
|---|---|---|
| AMPLIA THERAPEUTICS LIMITED | Directeur/Bestuurslid | 02-09-2015 |
Eerdere bekende functies van Robert Peach
| Bedrijven | Functie | Einde |
|---|---|---|
| ADALTA LIMITED | Directeur/Bestuurslid | 20-11-2024 |
| RECEPTOS INC | Oprichter | 27-08-2015 |
Apoptos, Inc.
 Apoptos, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule anticancer drugs | Oprichter | 01-05-2009 |
| BIOGEN INC. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Opleiding van Robert Peach
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
69
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Apoptos, Inc.
Apoptos, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule anticancer drugs | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
University of Otago
 University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Canterbury
 University of Canterbury Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AdAlta Ltd.
 AdAlta Ltd. BiotechnologyHealth Technology Discovers and develops i-body drugs to treat fibrotic diseases | Health Technology |
Amplia Therapeutics Ltd.
 Amplia Therapeutics Ltd. BiotechnologyHealth Technology Develops drug candidates for oncology and chronic fibrosis | Health Technology |
Avalia Immunotherapies Ltd.
 Avalia Immunotherapies Ltd. Medical/Nursing ServicesHealth Services Engages in developing immunotherapy’s that support the treatment of cancer and other diseases | Health Services |
